carbamates has been researched along with Acute Brain Injuries in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Whether repeated dosing would achieve greater protection remains to be examined." | 1.42 | Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. ( Impastato, RA; Katz, PS; Molina, PE; Rogers, EK; Sulzer, JK; Teng, SX, 2015) |
| " The effect of SNJ-1945 on α-spectrin degradation exhibited a U-shaped dose-response curve when treatment was initiated 15 min post-TBI." | 1.39 | Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model. ( Bains, M; Barnes, CC; Cebak, JE; Geddes, JW; Gilmer, LK; Hall, ED; Thompson, SN, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, J | 1 |
| Guo, J | 1 |
| Zhu, S | 1 |
| Wang, Q | 1 |
| Gao, R | 1 |
| Zhao, C | 1 |
| Feng, C | 1 |
| Qin, C | 2 |
| He, Z | 1 |
| Wang, Z | 1 |
| Zang, L | 1 |
| Li, GB | 1 |
| Liu, JY | 1 |
| Feng, XM | 1 |
| Zhang, BL | 1 |
| Zhang, RS | 1 |
| Katz, PS | 1 |
| Sulzer, JK | 1 |
| Impastato, RA | 1 |
| Teng, SX | 1 |
| Rogers, EK | 1 |
| Molina, PE | 1 |
| Tchantchou, F | 1 |
| Zhang, Y | 1 |
| Bains, M | 1 |
| Cebak, JE | 1 |
| Gilmer, LK | 1 |
| Barnes, CC | 1 |
| Thompson, SN | 1 |
| Geddes, JW | 1 |
| Hall, ED | 1 |
| Keck, CA | 1 |
| Thompson, HJ | 1 |
| Pitkänen, A | 1 |
| LeBold, DG | 1 |
| Morales, DM | 1 |
| Plevy, JB | 1 |
| Puri, R | 1 |
| Zhao, B | 1 |
| Dichter, M | 1 |
| McIntosh, TK | 1 |
| Blount, PJ | 1 |
| Nguyen, CD | 1 |
| McDeavitt, JT | 1 |
1 review available for carbamates and Acute Brain Injuries
| Article | Year |
|---|---|
Clinical use of cholinomimetic agents: a review.
Topics: Administration, Oral; Adult; Aged; Alzheimer Disease; Brain Injuries; Carbamates; Clinical Trials as | 2002 |
6 other studies available for carbamates and Acute Brain Injuries
| Article | Year |
|---|---|
The Role of Potassium Channels in Chronic Stress-Induced Brain Injury.
Topics: Animals; Brain; Brain Injuries; Carbamates; Disease Models, Animal; Female; Humans; Neuroprotective | 2021 |
Retigabine attenuates focal cerebral ischemic injury through inhibiting mitochondria-dependent apoptotic pathway.
Topics: Animals; Apoptosis; Brain Injuries; Carbamates; Caspase 3; Disease Models, Animal; Glutathione; JNK | 2018 |
Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury.
Topics: Animals; Arachidonic Acids; Benzamides; Benzodioxoles; Blood-Brain Barrier; Blotting, Western; Brain | 2015 |
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.
Topics: Animals; Arachidonic Acids; Biphenyl Compounds; Blood-Brain Barrier; Blotting, Western; Brain Injuri | 2013 |
Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.
Topics: Animals; Brain Injuries; Calpain; Carbamates; Cerebral Cortex; Cytoskeleton; Dose-Response Relations | 2013 |
The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain Edema; Brain Injuries; Carbamates; Cell Death; Cog | 2007 |